LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
26.01
+0.30 (1.17%)
At close: Apr 1, 2025, 4:00 PM
25.06
-0.95 (-3.65%)
After-hours: Apr 1, 2025, 6:14 PM EDT

LENZ Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
20.1635.1444.4418.31
Short-Term Investments
188.8730.65--
Cash & Short-Term Investments
209.0365.7944.4418.31
Cash Growth
217.70%48.05%142.75%-
Prepaid Expenses
2.771.452.20.02
Restricted Cash
0.11---
Total Current Assets
211.9267.2446.6418.32
Property, Plant & Equipment
1.990.370.280.01
Long-Term Deferred Charges
-2.74--
Other Long-Term Assets
1.40.020.030
Total Assets
215.370.3846.9518.34
Accounts Payable
4.265.714.760.46
Accrued Expenses
5.5812.674.290.79
Current Portion of Leases
0.570.140.1-
Current Income Taxes Payable
--0.35-
Total Current Liabilities
10.4118.519.51.25
Long-Term Leases
0.810.190.15-
Other Long-Term Liabilities
-0.120.07-
Total Liabilities
11.2218.839.711.25
Common Stock
05.915.915.9
Additional Paid-In Capital
348.92.521.10.25
Retained Earnings
-145.01-95.25-25.28-14.47
Comprehensive Income & Other
0.20.01--
Total Common Equity
204.08-86.81-18.27-8.31
Shareholders' Equity
204.0851.5537.2417.08
Total Liabilities & Equity
215.370.3846.9518.34
Total Debt
1.380.330.25-
Net Cash (Debt)
207.6565.4744.1918.31
Net Cash Growth
217.19%48.14%141.39%-
Net Cash Per Share
9.7633.424.671.96
Filing Date Shares Outstanding
27.5425.539.639.36
Total Common Shares Outstanding
27.529.749.639.36
Working Capital
201.5148.7337.1417.07
Book Value Per Share
7.42-8.91-1.90-0.89
Tangible Book Value
204.08-86.81-18.27-8.31
Tangible Book Value Per Share
7.42-8.91-1.90-0.89
Machinery
0.480.070.050.02
Leasehold Improvements
0.10.01--
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q